Hear the latest updates on Translational Science from top leaders in the scientific field during the Translational Science 2013 plenary sessions. Speakers are still being confirmed, and updated information is included on our sessions planned page.
Dr. Otis Brawley
April 18, 8:00-9:30 AM
Dr. Brawley is the Medical Director and Executive Vice President for the American Cancer Society. He is recognized as a leader in eliminating global health disparities and currently promotes cancer prevention, early detection and quality cancer treatment. He will speak on the unique role of Foundations in training and funding new translational investigators.
Dr. Margaret Anderson
April 18, 8:00-9:30 AM
Margaret Anderson is executive director of FasterCures/The Center for Accelerating Medical Solutions. She is responsible for defining the organization's strategic priorities and positions on key issues, developing its programmatic portfolio, and managing its operations. She has extensive experience in managing biomedical and public health initiatives and facilitating multi-sector collaborations.
Dr. Elias Zerhouni
April 18, 5:00-6:30 PM
A world-renowned leader in radiology research and an experience scientific leader, Dr. Zerhouni is a powerful voice for scientific innovation. He served as the 15th director of the National Institutes of Health from 2002 to 2008, where he oversaw the passage by Congress of the NIH Reform Act of 2006, created a Roadmap to stimulate and facilitate more efficient research, and encouraged innovation, particularly in the area of high-risk research. Most recently he serves at the President of R&D at Sanofi, SA.
Dr. Ezekiel Emanuel
April 19, 8:00-9:00 AM
We are pleased to announce that Dr. Ezekiel Emanuel, the Diane v.S. Levy and Robert M. Levy University Professor and Chair, Department of Medical Ethics and Health Policy at the University of Pennsylvania, Perelman School of Medicine, will be featured as a plenary speaker at Translational Science 2013.
Dr. Emanuel is internationally recognized for his forthright positions on medical ethics and health policy. Among many other publications, he has contributed to the Opinionator blogs in theNew York Times.
Dr. Christopher Austin
April 19, 12:00-1:00 PM
Dr. Austin is the newly appointed director of the National Center for Advancing Clinical and Translational Science (NCATS). He served as director of the NCATS Division of Pre-Clinical Innovation since the creation of the Center in December 2011.
Austin came to NIH in 2002 from Merck, where his work focused on genome-based discovery of novel targets and drugs. He began his NIH career as the senior advisor to the director for translational research at the National Human Genome Research Institute, where he initiated the Knockout Mouse Project and the Molecular Libraries Roadmap Initiative. Other NIH roles have included serving as director of the Therapeutics for Rare and Neglected Diseases program as well as the NIH Chemical Genomics Center and as scientific director of the NIH Center for Translational Therapeutics.
Austin earned a medical degree from Harvard Medical School and an undergraduate degree in biology from Princeton University. He completed clinical training in internal medicine and neurology at Massachusetts General Hospital as well as a fellowship in genetics at Harvard.